These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 8097524)

  • 1. Recombinant interleukin 12 cures mice infected with Leishmania major.
    Heinzel FP; Schoenhaut DS; Rerko RM; Rosser LE; Gately MK
    J Exp Med; 1993 May; 177(5):1505-9. PubMed ID: 8097524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
    Sypek JP; Chung CL; Mayor SE; Subramanyam JM; Goldman SJ; Sieburth DS; Wolf SF; Schaub RG
    J Exp Med; 1993 Jun; 177(6):1797-802. PubMed ID: 8098733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P
    J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.
    Heinzel FP; Rerko RM; Hatam F; Locksley RM
    J Immunol; 1993 May; 150(9):3924-31. PubMed ID: 8473741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.
    Heinzel FP; Sadick MD; Holaday BJ; Coffman RL; Locksley RM
    J Exp Med; 1989 Jan; 169(1):59-72. PubMed ID: 2521244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.
    Heinzel FP; Sadick MD; Mutha SS; Locksley RM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7011-5. PubMed ID: 1908085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice.
    Sommer F; Meixner M; Mannherz M; Ogilvie AL; Röllinghoff M; Lohoff M
    Int Immunol; 1998 Dec; 10(12):1853-61. PubMed ID: 9885906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
    Scharton TM; Scott P
    J Exp Med; 1993 Aug; 178(2):567-77. PubMed ID: 8101861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
    Varkila K; Chatelain R; Leal LM; Coffman RL
    Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice.
    Kremer IB; Gould MP; Cooper KD; Heinzel FP
    Infect Immun; 2001 Feb; 69(2):673-80. PubMed ID: 11159954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.
    Heinzel FP; Rerko RM; Ahmed F; Pearlman E
    J Immunol; 1995 Jul; 155(2):730-9. PubMed ID: 7608551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
    Heinzel FP; Maier RA
    Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma inhibits the efficacy of interleukin 1 to generate a Th2-cell biased immune response induced by Leishmania major.
    Wagner HM; Beuscher HU; Röllinghoff M; Solbach W
    Immunobiology; 1991 Jun; 182(3-4):292-306. PubMed ID: 1680802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
    Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
    J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
    Sadick MD; Heinzel FP; Holaday BJ; Pu RT; Dawkins RS; Locksley RM
    J Exp Med; 1990 Jan; 171(1):115-27. PubMed ID: 2104918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
    Melby PC; Yang YZ; Cheng J; Zhao W
    Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.